The work Plan for the Adjustment of the National Drug catalogue of basic Medical Insurance, Industrial injury Insurance and Maternity Insurance in 2022 and related documents were officially announced a few days ago. compared with the catalogue adjustment in previous years, the current round of medical insurance drug catalogue adjustment optimizes the scope of declaration, giving proper preference to patients with rare diseases, children and other special groups. Among them, the declaration conditions for drugs for rare diseases do not set a time limit of "approval for listing after January 1, 2017". At the same time, they are included in the catalogue of generic drugs encouraged by the state, and drugs that encourage research and development to declare the list of drugs for children can be declared in this year's health insurance catalogue. According to the current arrangement, if it goes well, the new round of national medical insurance drug catalogue adjustment will be officially launched on July 1, 2022, the results will be announced in November, and will be implemented on January 1, 2023. (Weibo Corp, Chinese government website)